Information Library
Results for: Cost control/reduction - Market analysis
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
A Blueprint for Clinical / Commercial Convergence
White Paper — August 5, 2010
The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities. -
Commercial – Identify, Promote and Prove Treatment Value
Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Jim Featherstone, Ph.D.
Hear from the Experts — March 25, 2009
Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice. -
Matthew Eberhart
Hear from the Experts — March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.
Page 1 of 1 (4 results)
